Skip to main content
SpringerLink
Log in

Effects of Fosinopril on Renal Function, Baroreflex Response and Noradrenaline Pressor Response in Conscious Normotensive Dogs

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

The blood pressure, renal function, baroreflex response of heart rate and noradrenaline (norepinephrine) pressor response were determined in conscious, normotensive, sodium-replete dogs that had received fosinopril. Oral administration of fosinopril at a dose of 1 mg/kg per day for 5 days decreased the systolic arterial pressure from 147.1±3 to 131.8±4.3 mmHg (p<0.05) and the mean arterial pressure from 99.7±3.9 to 87.5±2.8 mmHg (p<0.05), while heart rate was unchanged. A study of the noradrenaline pressor response showed a tendency to alleviate the increased MAP by fosinopril treatment, although this was not significant. There were no significant changes in the sensitivity of the baroreflex response in HR, although the setpoint was reduced. After 7 days of fosinopril treatment, the glomerular filtration rate had increased by 18.5% (p<0.05). The effective renal plasma flow tended to increase, leaving the filtration fraction unchanged. The renal vascular resistance was reduced by 11.3% (p<0.05). Fosinopril caused a significant 41.5% increase in urinary excretion of Na+ (p<0.05), along with an elevation of urinary excretion of K+ and Cl–. It is concluded that fosinopril can lower the blood pressure, reduce the noradrenaline pressor response and lower the cardiac baroreflex setpoint to noradrenaline. Oral administration of fosinopril for 7 days affects both the renal haemodynamics and electrolyte excretions in conscious, normotensive, sodium-replete dogs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Asaad, M.M. and Antonaccio, M.J., 1982. Vascular wall renin in spontaneously hypertensive rats: potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension, 4, 487-493

    Google Scholar 

  • Bovée, K.C., 1984. Canine Nephrology, (Harwal Publishing Co., Media, PA, USA), 78

    Google Scholar 

  • Bovée, K.C., Wong, P.C., Timmermans, P.B.M.W.M. annd Thoolen, M.J.M.C., 1991. Effects of nonpeptide angiotensin II receptor antagonist DuP753 on blood pressure and renal functions in spontaneously hypertensive PH dogs. American Journal of Hypertension, 4, 327S-333S

    Google Scholar 

  • Brun, C., 1951. A rapid method for the determination of para-aminohippuric acid in kidney function tests. Journal of Laboratory and Clinical Medicine, 37, 955-958

    Google Scholar 

  • Brunner, H.R., Kirshman, J.D., Sealey, J.E. and Laragh, J.H., 1971. Hypertension of renal origin: evidence for two different mechanisms. Science, 174, 1344-1346

    Google Scholar 

  • Bumpus, F.M., Sen, S., Smeby, R.R., Sweet, C., Ferrario, C.M. and Khosla, M.C., 1973. Use of angiotensin II antagonists in experimental hypertension. Circulation Research, 32(supplement), I150-I158

    Google Scholar 

  • Clappison, B.H., Anderson, W.P. and Johnston, C.L., 1981. Renal hemodynamics and renal kinins after angiotensin converting enzyme inhibitor. Kidney International, 20, 615-620

    Google Scholar 

  • Clough, D.P., Collis, M.G., Conway, J., Hatton, R. and Keddie, J.R., 1982. Interaction of angiotensin converting enzyme inhibitors with the function of the sympathetic nervous system. American Journal of Cardiology, 49, 1410-1414

    Google Scholar 

  • DeForrest, J.M., Waldron, T.L. and Antanaccio, M.J., 1982. Renal response to captopril in conscious dogs pretreated with indomethacin. American Journal of Physiology, 243, F543-F548

    Google Scholar 

  • DeForrest, J.M., Waldron, T.L., Harvey, C., Scalese, B., Rubin, B., Powell, J.R., Petrillo, E.W. and Cushman, D.W., 1989. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and pre-clinical in vivo pharmacology. Journal of Cardiovascular Pharmacology, 14, 730-736

    Google Scholar 

  • DeForrest, J.M., Waldron, T.L., Harvey, C., Scalese, B., Mitch, S., Powell, J.R., Petrillo, E.W. and Cushman, D.W., 1990. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models. Journal of Cardiovascular Pharmacology, 16, 139-146

    Google Scholar 

  • Faria, F.A.C. and Salgado, M.C.O., 1992. Facilitation of noradrenergic transmission by angiotensin in hypertensive rats. Hypertension, 19(supplement II), II30-II35

    Google Scholar 

  • Fernandez, M., Madero, R., Gonzales, D., Camacho, P., Villalpando, J. and Arriaga, J., 1994. Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients. Hypertension, 23(supplement I), I207-I210

    Google Scholar 

  • Hamlin, R.L. and Nakayama, T., 1998. Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles. Journal of Veterinary Internal Medicine, 12, 93-95

    Google Scholar 

  • Hoyer, J., Schulte, K.L. and Lenz, T., 1993. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clinical Pharmacokinetics, 24, 230-254

    Google Scholar 

  • Ichikawa, S., Johnson, J.A., Fowler, W.L. Jr., Payne, C.G., Kurz, K. and Keitzer, W.F., 1978. Pressor responses to norepinephrine in rabbits with 3 days and 30 days renal artery stenosis: the role of angiotensin II. Circulation Research, 43, 437-446

    Google Scholar 

  • Kelly, J.G. and O'Malley, K., 1990. Clinical pharmacokinetics of the newer ACE inhibitors: a review. Clinical Pharmacokinetics, 19, 177-196

    Google Scholar 

  • Kimbrough, H.M., Vaughan, D., Carey, R.M. and Ayers, C.R., 1977. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circulation Research, 40, 174-178

    Google Scholar 

  • Lee, W.B. and Lumbers, E.R., 1981. Angiotensin and the cardiac baroreflex response to phenylephrine. Clinical and Experimental Pharmacology and Physiology, 8, 109-117

    Google Scholar 

  • Mitchell, H.C., Smith, R.D., Cutler, R.E., Sica, D., Videen, J., Thompsen-Bell, S., Jones, K., Bardley-Guidry, C. and Toto, R.D., 1997. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibitor: a prospective double blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency. American Journal of Kidney Diseases, 29, 897-906

    Google Scholar 

  • Mundoch, D. and McTavish, D., 1992. Fosinopril: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension. Drugs, 43, 123-140

    Google Scholar 

  • Oren, S., Messerli, F.H., Grossman, E., Garavaglia, G.E. and Frohlich, E.D., 1991. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension. Journal of the American College of Cardiology, 17, 1183-1187

    Google Scholar 

  • Potter, E.K. and Reid, I.A., 1985. Intravertebral angiotensin II inhibits cardiac vagal efferent activity in dogs. Neuroendocrinology, 40, 493-496

    Google Scholar 

  • Reid, I.A. and Chou, L., 1990. Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits. Endocrinology, 126, 2749-2756

    Google Scholar 

  • Rizzoni, D., Castellaro, M., Porteri, E., Bettoni, G., Muiesan, M.L., Cinelli, A. and Rosei, A., 1995. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension, 26, 118-123

    Google Scholar 

  • Sokabe, H., 1966. Renin activity of the kidney in the spontaneously hypertensive rat. Japanese Journal of Physiology, 16, 380-388

    Google Scholar 

  • Sweet, C.S., Gaul, S.L., Reitz, P.M., Blaine, E.H. and Ribeiro, L.T., 1983. Mechanisms of action of enalapril in experimental hypertension and acute left ventricular failure. Journal of Hypertension, 1(supplement 1), 53-63

    Google Scholar 

  • Weber, M.A., 1992. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors. Journal of Cardiovascular Pharmacology, 20(supplement 10), S7-S12

    Google Scholar 

  • Young, M.K. Jr. and Raisz, L.G., 1952. An anthrone procedure for determination of inulin in biological fluids. Proceedings of the Society for Experimental Biological Medicine, 80, 771-774

    Google Scholar 

  • Zimmerman, B.G., 1973. Blockade of adrenergic potentiation effect of angiotensin by 1-sar-8-ala-angiotensin II. Journal of Pharmacology and Experimental Therapeutics, 185, 486-592

    Google Scholar 

  • Zimmerman, B.G., 1981. Adrenergic facilitation by angiotensin: does it serve a phsyiological function? Clinical Science, 60, 343-348

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Henri Dunant Road, Patumwan, Bangkok, 10330, Thailand

    C. Buranakarl, A. Kijtawornrat & P. Nampimoon

Authors
  1. C. Buranakarl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Kijtawornrat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Nampimoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buranakarl, C., Kijtawornrat, A. & Nampimoon, P. Effects of Fosinopril on Renal Function, Baroreflex Response and Noradrenaline Pressor Response in Conscious Normotensive Dogs. Vet Res Commun 25, 355–366 (2001). https://doi.org/10.1023/A:1010638609216

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010638609216

Search

Navigation